ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Piaget's Stage 3 of Cognitive Development
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Case Studies
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Imaging Studies I: Kidney, Ureter, and Bladder Studies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 9, 2026

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Alice Ballone1, Federica Centorrino2, Christian Ottmann3,4
1Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands. A.Ballone@tue.nl.
Targeting 14-3-3 protein-protein interactions (PPIs) offers a novel therapeutic strategy for diseases like cancer. This review explores modulating 14-3-3 PPIs to develop small molecule drugs.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: